GlassScriptPhysician profile
Carrie Roitstein
NPI 1134180060
$1,469.24
in general payments reported to CMS, 2019-2025
10 companies · $551 in 2025
The $551 reported for 2025 was more than what 80% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $96.18 · 2021: $168 · 2022: $179 · 2023: $172 · 2024: $74.16 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.74 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $509.67 | 2020-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Eyevance Pharmaceuticals LLC | $402.16 | 2019-2023 | Flarex |
| Glaukos Corporation | $146.58 | 2025 | Photrexa Viscous and Photrexa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $124.55 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $94.53 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $73.95 | 2025 | |
| Alcon Vision LLC | $41.34 | 2024-2025 | Total30 |
| Menicon America INC | $27.50 | 2019 | |
| Horizon Therapeutics Plc | $27.28 | 2023 | Tepezza |
| Lombart Brothers, INC. | $21.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Roitstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.